Table: Kubota Pharmaceutical Holdings -2017 group results (IFRS)

Kubota Pharmaceutical Holdings

13/02/2018 06:01

Feb 13 (Reuters)-  
              Kubota Pharmaceutical Holdings Co., Ltd.  
              CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)  
                   Year ended       Year ended        Year to         NEXT   
                Dec 31, 2017     Dec 31, 2016    Dec 31, 2018       YEAR     
                   LATEST          YEAR-AGO         COMPANY       COMPANY    
                   RESULTS          RESULT         FORECAST     H1 FORECAST  
  Sales             0 mln          846 mln                                   
  Operating       loss 3.62       loss 4.07        loss 3.50                 
  Pretax          loss 3.45       loss 3.91        loss 3.37                 
  Net             loss 3.45       loss 3.91        loss 3.37                 
  EPS Basic    loss 90.85 yen  loss 104.52 yen  loss 88.60 yen               
  EPS Diluted  loss 90.85 yen  loss 104.52 yen                               
  Ann Div            NIL             NIL              NIL                    
  -Q2 Div            NIL             NIL              NIL                    
  -Q4 Div            NIL             NIL              NIL                    
  
  NOTE - Kubota Pharmaceutical Holdings Co., Ltd..  
  (Figures are reported based on international accounting rules (IFRS).)  
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half  
  dividend and Q4 to the second-half dividend announced before a new corporate law in  
  2006 allowed companies to pay and report dividends on a quarterly basis. 
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4596.T 
  ((Tokyo Headline News Desk +813 6441 1812))